Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Aug 2;13(8):e0201793.
doi: 10.1371/journal.pone.0201793. eCollection 2018.

MALDI-TOF analysis of blood serum proteome can predict the presence of monoclonal gammopathy of undetermined significance

Affiliations

MALDI-TOF analysis of blood serum proteome can predict the presence of monoclonal gammopathy of undetermined significance

Francisca Barceló et al. PLoS One. .

Abstract

Monoclonal gammopathy of undetermined significance (MGUS) is a plasma cell dyscrasia that can progress to malignant multiple myeloma (MM). Specific molecular biomarkers to classify the MGUS status and discriminate the initial asymptomatic phase of MM have not been identified. We examined the serum peptidome profile of MGUS patients and healthy volunteers using MALDI-TOF mass spectrometry and developed a predictive model for classifying serum samples. The predictive model was built using a support vector machine (SVM) supervised learning method tuned by applying a 20-fold cross-validation scheme. Predicting class labels in a blinded test set containing randomly selected MGUS and healthy control serum samples validated the model. The generalization performance of the predictive model was evaluated by a double cross-validation method that showed 88% average model accuracy, 89% average sensitivity and 86% average specificity. Our model, which classifies unknown serum samples as belonging to either MGUS patients or healthy individuals, can be applied to clinical diagnosis.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. 20-fold cross-validation scheme.
Fig 2
Fig 2. Double cross-validation scheme.
It highlights the two nested loops. The outer cross-validation loop provides 10 performance estimates from predicting the corresponding test set by the optimized model built in the inner 20 fold cross-validation loop. The data set used to build and tune the model in the inner cross-validation loop is completely independent of the test set used in the outer iteration.
Fig 3
Fig 3. Classification process of an unknown serum sample.
n technical replicates from serum sample raw mass spectra are pre-processed and features selected. The correlation threshold (rth) sets the k technical replicates passing the intra-experimental quality control (QC). The SVM predictive model classifies the k technical replicates. The majority voter assigns the serum sample predicted class. The parameters determined from the processing of the training set and the building of the predictive model are shaded.

References

    1. Korde N, Kristinsson SY, Landgren O (2011) Monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM): novel biological insights and development of early treatment strategies. Blood 117: 5573–5581. 10.1182/blood-2011-01-270140 - DOI - PMC - PubMed
    1. Landgren O, Kyle RA, Pfeiffer RM, Katzmann JA, Caporaso NE, Hayes RB, et al. (2009) Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study. Blood 113: 5412–5417. 10.1182/blood-2008-12-194241 - DOI - PMC - PubMed
    1. Mangiacavalli S, Cocito F, Pochintesta L, Pascutto C, Ferretti V, Varettoni M, et al. (2013) Monoclonal gammopathy of undetermined significance: a new proposal of workup. Eur J Haematol 91: 356–360. 10.1111/ejh.12172 - DOI - PubMed
    1. Kyle RA, San-Miguel JF, Mateos MV, Rajkumar SV (2014) Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma. Hematol Oncol Clin North Am 28: 775–790. 10.1016/j.hoc.2014.06.005 - DOI - PubMed
    1. Kyle RA, Therneau TM, Rajkumar SV, Larson DR, Plevak MF, Offord JR, et al. (2006) Prevalence of monoclonal gammopathy of undetermined significance. N Engl J Med 354: 1362–1369. 10.1056/NEJMoa054494 - DOI - PubMed

Publication types